Schwannoma
12
6
6
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (12)
Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study
Evaluation of the CONVIVO System
Multicenter Observational Study of Multimodal AI for Upper GI Mesenchymal Tumor Diagnosis
SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)
Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
Establishing Prospective Mediastinal Tumor Database of PUMCH
Use of Non-invasive Optical Analysis in Neurosurgery
Stereotactic Body Radiotherapy for Spine Tumors
Evolution of Cochleovestibular Schwannomas
MRI Scan and Intra-labyrinthine Schwannoma
Hippocampal Radiation Exposure and Memory
Assessment of Volumetric Growth Rates of Spinal Intradural Extramedullary Schwannoma